financetom
Business
financetom
/
Business
/
STMicroelectronics Fiscal Q2 Earnings, Revenue Decline; Issues Fiscal Q3 Revenue Outlook
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
STMicroelectronics Fiscal Q2 Earnings, Revenue Decline; Issues Fiscal Q3 Revenue Outlook
Jul 25, 2024 1:25 AM

04:07 AM EDT, 07/25/2024 (MT Newswires) -- STMicroelectronics ( STM ) reported fiscal Q2 earnings Thursday of $0.38 per diluted share, down from $1.06 a year earlier.

Analysts polled by Capital IQ expected $0.35.

Net revenue for the quarter ended June 29 was $3.23 billion, down from $4.33 billion a year earlier. Analysts surveyed by Capital IQ expected $3.27 billion.

For fiscal Q3, the company expects revenue of $3.25 billion at the mid-point. Analysts polled by Capital IQ expect $3.55 billion.

Price: 40.90, Change: +1.36, Percent Change: +3.44

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Tesla launches new Model 3 long-range variant at $42,490, website shows
Tesla launches new Model 3 long-range variant at $42,490, website shows
Jul 11, 2024
(Reuters) - Tesla on Thursday launched a new rear-wheel drive variant of its Model 3 long-range vehicle, at a price $5,000 lower than the all-wheel drive version, according to the electric vehicle maker's website. The new Model 3 long-range variant is priced at $42,490. There were no changes to the prices of the base Model 3, the long-range all-wheel drive...
China approves CSPC Pharma's RSV vaccine for clinical trials
China approves CSPC Pharma's RSV vaccine for clinical trials
Jul 11, 2024
SHANGHAI, July 12 (Reuters) - China's National Medical Products Administration has given regulatory clearance for CSPC Pharmaceutical Group's ( CHJTF ) respiratory syncytial virus (RSV) vaccine candidate to begin human clinical trials, the drugmaker said. RSV, which shows symptoms similar to a cold but can be fatal for young children and older adults, contributed to 17.6% of one group of...
Australia's ANZ to probe allegations of inflated bond trades, CEO tells staff
Australia's ANZ to probe allegations of inflated bond trades, CEO tells staff
Jul 11, 2024
(Reuters) - Australia's ANZ Group ( ANZGF ) plans to get to the bottom of allegations of misconduct that have been raised against its bond trading operations and will hold people accountable for any wrongdoing, its CEO said in an email to staff. The email, a copy of which has been reviewed by Reuters, comes after media reported that the...
India Morning Newsletter, July 12
India Morning Newsletter, July 12
Jul 11, 2024
To access a PDF version of this newsletter, please click here If you would like to receive this newsletter via email, please register at: https://solutions.refinitiv.com/MNCIndiaSubscriptionpage For an index of our newsletters click on ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved